MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Sangamo Biosciences Company Profile (NASDAQ:SGMO)

Consensus Ratings for Sangamo Biosciences (NASDAQ:SGMO) (?)
Ratings Breakdown: 7 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.40 (218.89% upside)

Analysts' Ratings History for Sangamo Biosciences (NASDAQ:SGMO)
Show:
DateFirmActionRatingPrice TargetActions
6/9/2016Jefferies GroupReiterated RatingBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2016WedbushReiterated RatingOutperform$30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/3/2016Wells FargoInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/10/2016JPMorgan Chase & Co.Reiterated RatingOverweight$16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/17/2015Janney Montgomery ScottInitiated CoverageBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/28/2015Piper JaffrayReiterated RatingBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/4/2015Cowen and CompanyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2015BMO Capital MarketsReiterated RatingOutperform$19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/29/2014 forward)
Earnings History for Sangamo Biosciences (NASDAQ:SGMO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
5/2/2016Q116($0.24)($0.23)$5.49 million$3.94 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/9/2016Q415($0.21)($0.20)$9.86 million$9.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2015Q315($0.25)($0.13)$13.09 million$8.57 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215($0.13)($0.17)$14.72 million$8.36 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/22/2015Q115($0.13)($0.08)$12.50 million$13.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/10/2015Q414($0.09)($0.06)$14.50 million$15.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/22/2014Q314($0.04)($0.11)$8.27 million$12.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/23/2014Q214($0.14)($0.10)$7.84 million$10.38 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q114($0.13)($0.12)$6.59 million$8.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/11/2014Q413($0.10)($0.13)$8.90 million$6.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2013Q313($0.11)($0.11)$5.52 million$5.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2013Q2 2013($0.12)($0.10)$4.77 million$6.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2013Q1 2013($0.17)($0.13)$3.79 million$4.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/6/2013Q4 2012($0.12)($0.07)$5.95 million$8.93 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2012Q312($0.14)($0.11)$3.80 million$4.90 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2012($0.15)($0.11)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2012($0.16)($0.14)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2011($0.16)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/27/2011($0.16)($0.20)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2011($0.17)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2011($0.19)($0.18)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Sangamo Biosciences (NASDAQ:SGMO)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20161($0.25)($0.25)($0.25)
Q3 20161($0.27)($0.27)($0.27)
Q4 20161($0.31)($0.31)($0.31)
(Data provided by Zacks Investment Research)
Dividend History for Sangamo Biosciences (NASDAQ:SGMO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Sangamo Biosciences (NASDAQ:SGMO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
8/1/2015Ra Capital Management, LlcMajor ShareholderSell27,770$12.82$356,011.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/30/2015Ra Capital Management, LlcMajor ShareholderSell109,590$12.42$1,361,107.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2015Ra Capital Management, LlcMajor ShareholderSell1,407$12.41$17,460.87View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/28/2015Ra Capital Management, LlcMajor ShareholderSell60,081$12.11$727,580.91View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/25/2015Ra Capital Management, LlcMajor ShareholderSell47,429$12.31$583,850.99View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/24/2015Ra Capital Management, LlcMajor ShareholderSell124,050$12.28$1,523,334.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2015Ra Capital Management, LlcMajor ShareholderBuy37,215$12.26$456,255.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2015Edward O Lanphier IICEOSell25,000$10.43$260,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/13/2015Henry Ward WolffCFOSell12,000$10.00$120,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2015Ra Capital Management, LlcMajor ShareholderSell82,700$16.01$1,324,027.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Ra Capital Management, LlcMajor ShareholderSell250,500$16.55$4,145,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2015Ra Capital Management, LlcMajor ShareholderSell83,500$15.50$1,294,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/6/2015Ra Capital Management, LlcMajor ShareholderSell135,101$14.29$1,930,593.29View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2015Dale G AndoCMOSell15,000$12.29$184,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/5/2015Ra Capital Management, LlcMajor ShareholderSell115,102$14.13$1,626,391.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/4/2015Ra Capital Management, LlcMajor ShareholderSell70,640$13.10$925,384.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015Ra Capital Management, LlcMajor ShareholderSell76,833$12.86$988,072.38View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2015William R RingoDirectorSell2,200$12.44$27,368.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2015Philip D GregorySVPSell15,000$12.39$185,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/30/2015Ra Capital Management, LlcMajor ShareholderSell65,884$13.40$882,845.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/29/2015Ra Capital Management, LlcMajor ShareholderSell155,675$13.53$2,106,282.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2015Ra Capital Management, LlcMajor ShareholderSell148,689$13.43$1,996,893.27View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2015Ra Capital Management, LlcMajor ShareholderSell263,437$13.55$3,569,571.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2015Ra Capital Management, LlcMajor ShareholderSell51,597$13.27$684,692.19View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/22/2015Ra Capital Management, LlcMajor ShareholderSell56,396$13.56$764,729.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2015Ra Capital Management, LlcMajor ShareholderSell56,060$13.12$735,507.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2015Ra Capital Management, LlcMajor ShareholderSell29,659$13.03$386,456.77View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2015Ra Capital Management, LlcMajor ShareholderSell83,300$12.40$1,032,920.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/7/2015Ra Capital Management, LlcMajor ShareholderBuy35,736$12.09$432,048.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/5/2015Dale G AndoCMOSell15,000$12.29$184,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2015William R RingoDirectorSell3,000$12.98$38,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/30/2015Ra Capital Management, LlcMajor ShareholderBuy124,500$13.45$1,674,525.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2015Ra Capital Management, LlcMajor ShareholderBuy74,844$13.29$994,676.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/25/2015Ra Capital Management, LlcMajor ShareholderBuy166,000$13.63$2,262,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/22/2015Ra Capital Management, LlcMajor ShareholderSell352,750$14.86$5,241,865.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/17/2015Ra Capital Management, LlcMajor ShareholderBuy41,500$14.02$581,830.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/16/2015Ra Capital Management, LlcMajor ShareholderSell21,829$14.09$307,570.61View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2015Edward O Lanphier IICEOSell25,000$15.33$383,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2015Ra Capital Management, LlcMajor ShareholderBuy21,829$13.16$287,269.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2015Ra Capital Management, LlcMajor ShareholderSell3,055$14.78$45,152.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/11/2015Ra Capital Management, LlcMajor ShareholderBuy116,992$14.48$1,694,044.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2015Henry Ward WolffCFOSell12,000$15.31$183,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2015Ra Capital Management, LlcMajor ShareholderBuy83,000$14.91$1,237,530.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/9/2015Ra Capital Management, LlcMajor ShareholderSell69,856$16.27$1,136,557.12View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/8/2015Ra Capital Management, LlcMajor ShareholderBuy121,876$15.49$1,887,859.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/7/2015Ra Capital Management, LlcMajor ShareholderBuy33,667$15.42$519,145.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2015Dale G AndoCMOSell15,000$14.94$224,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2015William R RingoDirectorSell2,200$14.95$32,890.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2015Ra Capital Management, LlcMajor ShareholderBuy179,031$15.38$2,753,496.78View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/3/2015Ra Capital Management, LlcMajor ShareholderBuy195,126$16.61$3,241,042.86View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2015Philip D GregorySVPSell15,000$15.15$227,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2015Ra Capital Management, LlcMajor ShareholderSell250,000$18.01$4,502,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/28/2015Ra Capital Management, LlcMajor ShareholderBuy84,000$17.10$1,436,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/27/2015Ra Capital Management, LlcMajor ShareholderBuy256,187$17.65$4,521,700.55View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/26/2015Ra Capital Management, LlcMajor ShareholderBuy210,013$18.14$3,809,635.82View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/25/2015Ra Capital Management, LlcMajor ShareholderBuy84,000$19.42$1,631,280.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2015Ra Capital Management, LlcMajor ShareholderBuy101,808$21.22$2,160,365.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Henry Ward WolffCFOSell10,000$18.00$180,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/19/2015Ra Capital Management, LlcMajor ShareholderSell17,808$24.28$432,378.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/18/2015Ra Capital Management, LlcMajor ShareholderSell84,000$23.74$1,994,160.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2015Ra Capital Management, LlcMajor ShareholderBuy52,161$23.02$1,200,746.22View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/16/2015Edward O Lanphier IICEOSell25,000$17.29$432,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/13/2015Ra Capital Management, LlcMajor ShareholderBuy71,319$22.76$1,623,220.44View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2015Ra Capital Management, LlcMajor ShareholderSell123,480$23.40$2,889,432.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/10/2015Ra Capital Management, LlcMajor ShareholderBuy12,522$22.30$279,240.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2015Ra Capital Management, LlcMajor ShareholderBuy258,377$22.25$5,748,888.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/6/2015Ra Capital Management, LlcMajor ShareholderSell61,483$24.10$1,481,740.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015Ra Capital Management, LlcMajor ShareholderSell84,000$18.21$1,529,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/3/2015William R RingoDirectorSell2,200$17.21$37,862.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/2/2015Philip D GregorySVPSell15,000$17.26$258,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/28/2015Ra Capital Management, LlcMajor ShareholderBuy42,000$18.10$760,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/27/2015Ra Capital Management, LlcMajor ShareholderSell32,196$19.37$623,636.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/26/2015Ra Capital Management, LlcMajor ShareholderBuy74,194$19.57$1,451,976.58View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/20/2015Ra Capital Management, LlcMajor ShareholderSell35,319$18.40$649,869.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/19/2015Ra Capital Management, LlcMajor ShareholderSell6,720$18.51$124,387.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2015Ra Capital Management, LlcMajor ShareholderSell11,172$18.11$202,324.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/14/2015Ra Capital Management, LlcMajor ShareholderSell15,380$18.61$286,221.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2015Ra Capital Management, LlcMajor ShareholderSell15,409$18.46$284,450.14View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2015Ra Capital Management, LlcMajor ShareholderBuy42,000$18.04$757,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/12/2015Saira RamasastryDirectorSell10,000$15.00$150,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2015Ra Capital Management, LlcMajor ShareholderBuy42,000$19.65$825,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/7/2015Ra Capital Management, LlcMajor ShareholderSell34,688$18.52$642,421.76View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/6/2015Ra Capital Management, LlcMajor ShareholderSell7,312$18.42$134,687.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015Dale G AndoCMOSell15,000$12.93$193,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/5/2015Ra Capital Management, LlcMajor ShareholderBuy42,000$18.23$765,660.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/3/2015William R RingoDirectorSell2,200$12.70$27,940.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/2/2015Philip D GregorySVPSell15,000$12.86$192,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/16/2015Edward O Lanphier IICEOSell25,000$14.22$355,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/12/2015Henry Ward WolffCFOSell12,000$15.87$190,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015Dale G AndoCMOSell15,000$15.19$227,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/5/2015William R RingoDirectorSell2,200$15.20$33,440.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014Edward O Lanphier IICEOSell25,000$15.40$385,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/15/2014John William LarsonDirectorSell10,000$16.28$162,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/9/2014John William LarsonDirectorSell10,000$12.00$120,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/1/2014Philip D GregorySVPSell15,000$11.68$175,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/17/2014Edward O Lanphier IICEOSell25,000$11.23$280,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014John William LarsonDirectorSell10,000$12.00$120,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Philip D GregorySVPSell15,000$11.91$178,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2014John William LarsonDirectorSell10,000$12.02$120,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/10/2014Henry Ward WolffCFOSell2,000$10.10$20,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/6/2014Dale G AndoCMOSell15,000$10.72$160,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2014Philip D GregorySVPSell15,000$10.80$162,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/15/2014Edward O Lanphier IICEOSell25,000$12.14$303,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Henry Ward WolffCFOSell2,000$12.31$24,620.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2014Dale G AndoCMOSell15,000$12.20$183,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2014John William LarsonDirectorSell10,000$12.81$128,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2014Edward O Lanphier IICEOSell25,000$13.95$348,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2014Henry Ward WolffCFOSell10,000$14.17$141,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/5/2014Dale G AndoCMOSell15,000$12.99$194,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014John William LarsonDirectorSell10,000$12.56$125,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2014Philip D GregorySVPSell15,000$12.54$188,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/18/2014Edward O Lanphier IICEOSell25,000$12.16$304,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2014Henry Ward WolffCFOSell15,000$13.26$198,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/1/2014Philip D GregorySVPSell15,000$15.66$234,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/23/2014Saira RamasastryDirectorSell5,550$15.53$86,191.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2014Edward O Lanphier IICEOSell25,000$16.41$410,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2014Henry Ward WolffCFOSell15,000$15.62$234,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/2/2014Philip D GregorySVPSell15,000$12.85$192,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2014Edward Lanphier IICEOSell25,000$13.14$328,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/1/2014Philip GregorySVPSell15,000$13.68$205,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2014Dale AndoCMOSell15,000$13.64$204,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/28/2014John William LarsonDirectorSell10,000$13.48$134,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2014Edward Lanphier IICEOSell25,000$14.20$355,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2014Henry Ward WolffCFOSell15,000$15.72$235,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/26/2014Dale AndoCMOSell15,000$18.65$279,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2014Philip GregoryInsiderSell15,000$22.38$335,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014Edward Lanphier IICEOSell50,000$23.22$1,161,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2014Saira RamasastryDirectorSell10,000$23.26$232,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2014Steven MentoDirectorSell6,103$22.77$138,965.31View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2014Edward Lanphier IICEOSell50,000$18.09$904,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/27/2014Dale AndoCMOSell15,000$18.58$278,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/10/2014Henry Ward WolffCFOSell10,000$18.69$186,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/2/2014Philip GregoryVPSell15,000$13.56$203,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2013Dale AndoCMOSell15,000$14.37$215,550.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013Edward Lanphier IICEOSell25,000$10.11$252,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/5/2013Philip D GregoryVPSell15,000$9.60$144,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2013Dale G AndoCMOSell15,000$10.39$155,850.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/21/2013Paul B ClevelandDirectorSell10,000$10.93$109,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/15/2013Edward O Lanphier IICEOSell25,000$11.32$283,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/10/2013Henry Ward WolffCFOSell10,000$11.28$112,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/1/2013Philip D GregoryVPSell15,000$10.54$158,100.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/16/2013Edward Lanphier IICEOSell25,000$11.29$282,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2013Henry Ward WolffCFOSell10,000$10.86$108,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Paul ClevelandDirectorSell7,278$10.30$74,963.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/3/2013Philip GregoryVPSell15,000$10.33$154,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2013Dale AndoCMOSell15,000$10.04$150,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2013Edward Lanphier IICEOSell25,000$10.12$253,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2013Henry Ward WolffCFOSell10,000$10.00$100,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Philip GregoryVPSell15,000$9.89$148,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2013Philip D GregoryVPSell15,000$10.04$150,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/26/2013Dale G AndoCMOSell15,000$10.09$151,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2013Edward O Lanphier IICEOSell25,000$10.00$250,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/17/2013Henry Ward WolffCFOSell10,000$10.00$100,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/15/2013Paul B ClevelandDirectorSell8,000$9.59$76,720.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/3/2013Philip D GregoryVPSell3,000$7.88$23,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/28/2013Dale G AndoCMOSell15,000$8.32$124,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2013Henry Ward WolffCFOSell10,000$10.00$100,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2012Dale G AndoCMOSell17,000$5.92$100,640.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2012John William LarsonDirectorSell15,000$5.64$84,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2012Dale G AndoCMOSell15,000$5.60$84,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/4/2012John William LarsonDirectorSell15,000$5.30$79,500.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Sangamo Biosciences (NASDAQ:SGMO)
DateHeadline
06/27/16 10:29 AMNext Weeks Broker Price Targets For Sangamo BioSciences, Inc. (NASDAQ:SGMO) - Fiscal Standard
06/26/16 10:44 AMSangamo BioSciences Inc. (SGMO) Jumps 5.34% on June 23 - Equities.com
06/24/16 06:28 PMStrong Sell Calls Recommendations For Sangamo BioSciences, Inc. (NASDAQ:SGMO) At 0 - Investor Newswire
06/21/16 10:40 AMCompany Update (NASDAQ:SGMO): Sangamo Biosciences, Inc. Announces FDA Clearance of Investigational New ... - Smarter Analyst
06/21/16 10:40 AMSangamo Biosciences Inc. (NASDAQ:SGMO) Stock Momentum Hits Weakness - CML News
06/20/16 06:02 PMSangamo Biosciences to start trials for Hunter Syndrome treatment
06/20/16 07:52 AMSangamo BioSciences Gets FDA Approval For IND For ZFN-Mediated Genome Editing Treatment Of MPS II - Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, disclosed Monday that the Food and Drug Administration (FDA) has cleared its Investigational New Drug application (IND) for SB-913. The drug candidate is a zinc finger nuclease (ZFN)-mediated approach designed as a single treatment with the potential to offer a long-lasting therapy for Mucopolysaccharidosis Type II (MPS II, Hunter syndrome). According to the company, the IND is now active and allowed it to commence a Phase 1/2 clinical study to assess the safety, tolerability and potential efficacy in adults with MPS II. Sangamo BioSciences' President and CEO, Sandy Macrae, commented, "Our gene-based approach is designed to give the patient ...Full story available on Benzinga.com
06/20/16 06:19 AMSangamo BioSciences Announces FDA Clearance of Investigational New Drug Application for ZFN-Mediated Genome Editing Treatment of MPS II - [at noodls] - RICHMOND, Calif., June 20, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced that the U.S. Food and Drug Administration (FDA) has cleared ...
06/17/16 06:04 PMStrong Buy Calls Count For Sangamo BioSciences, Inc. (NASDAQ:SGMO) At 7 - Investor Newswire
06/15/16 03:56 PMSANGAMO BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Amendments to Articles of Inc. -
06/14/16 11:08 AMValuable Price Trends to Observe: Insys Therapeutics, Inc. (NASDAQ:INSY) , Sangamo BioSciences, Inc. (NASDAQ ... - Street Updates
06/14/16 11:08 AMAnalyst Price Target Update on Sangamo BioSciences (NASDAQ:SGMO) - TheFounders Daily
06/13/16 09:20 AMEarnings Estimates Highlight: BlackRock, Inc. (NYSE:BLK), Sangamo Biosciences Inc. (NASDAQ:SGMO) - Beacon Chronicle
06/13/16 07:50 AMSangamo BioSciences, Inc. breached its 50 day moving average in a Bearish Manner : SGMO-US : June 13, 2016 -
06/07/16 06:37 PMSangamo BioSciences Inc. (SGMO) Jumps 6.08% on June 06 - Equities.com
06/07/16 09:08 AMSangamo Biosciences Inc. (NASDAQ:SGMO) Soared 6.08%: B. Riley Financial (NASDAQ:RILY), China Pharma ... - KC Register
06/04/16 06:27 PMEarnings Stocks Analysis: Mid-America Apartment Communities Inc. (NYSE:MAA), Sangamo Biosciences Inc ... - Beacon Chronicle
06/02/16 06:51 PMCompany Update (NASDAQ:SGMO): Sangamo Biosciences, Inc. Announces Retirement Of Edward Lanphier As ... - Smarter Analyst - FierceBiotechCompany Update (NASDAQ:SGMO): Sangamo Biosciences, Inc. Announces Retirement Of Edward Lanphier As ...Smarter AnalystSangamo Biosciences, Inc. (NASDAQ:SGMO), the leader in therapeutic genome editing, today announced the company has appointed Alexander 'Sandy' Macrae, M.B., Ch.B, Ph.D., MRCP, as president and chief executive officer to succeed current president ...Sangamo Biosciences Inc. (NASDAQ:SGMO) missed earnings on 3 occasionsZergwatchUpgrades And Downgrades For Sangamo BioSciences, Inc. (NASDAQ:SGMO)Risers & FallersStock Trending Up: Sangamo Biosciences Inc. (NASDAQ:SGMO)The PostStock Tick Tock -Seeking Alpha -Sonoran Weekly Reviewall 11 news articles »
06/01/16 03:25 PMSangamo BioSciences Announces Presentation at the Jefferies 2016 Healthcare Conference - [at noodls] - RICHMOND, Calif., June 1, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Edward Lanphier, Sangamo's founder and former president ...
06/01/16 09:19 AMStock Review and Earnings Check on Sangamo BioSciences, Inc. (NASDAQ:SGMO) - HNN - Stock Review and Earnings Check on Sangamo BioSciences, Inc. (NASDAQ:SGMO)HNNInvestors and analysts are typically super focused on company earnings numbers when they are reported. Company earnings are a good way to evaluate the company profitability. Currently, sell-side analysts are expecting Sangamo BioSciences, Inc.and more »
06/01/16 06:23 AMSangamo BioSciences Announces Retirement Of Edward Lanphier As President And CEO; Sandy Macrae Named As Successor - [at noodls] - RICHMOND, Calif., June 1, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, today announced the company has appointed Alexander 'Sandy' Macrae, M.B., ...
06/01/16 06:16 AMSANGAMO BIOSCIENCES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhib -
05/30/16 10:16 PMSangamo Biosciences Incorporated (NASDAQ:SGMO) Sellers Increased By 3.61% Their Shorts - HNN - Sangamo Biosciences Incorporated (NASDAQ:SGMO) Sellers Increased By 3.61% Their ShortsHNNThe short interest to Sangamo Biosciences Incorporated's float is 16.8%. The stock increased 1.99% or $0.13 on May 27, hitting $6.67. About 360,375 shares traded hands. Sangamo Biosciences, Inc. (NASDAQ:SGMO) has risen 3.73% since October 22, ...
05/30/16 10:16 PMStrong Sell Calls Count For Sangamo BioSciences, Inc. (NASDAQ:SGMO) At 0 - Investor Newswire - Strong Sell Calls Count For Sangamo BioSciences, Inc. (NASDAQ:SGMO) At 0Investor NewswireThe Sell calls on Sangamo BioSciences, Inc. (NASDAQ:SGMO) were 0. Two months earlier 7 were the Strong Buy calls whereas Strong Sell calls were 0. During this period, the hold calls were 0. The buy recommendations were 0 and sell calls count was 0.and more »
05/27/16 10:51 AMCould Sangamo Biosciences, Inc. Change Direction After Today's Huge Decline? - Wall Street Hints and News - Could Sangamo Biosciences, Inc. Change Direction After Today's Huge Decline?Wall Street Hints and NewsThe stock of Sangamo Biosciences, Inc. (NASDAQ:SGMO) is a huge mover today! The stock decreased 2.97% or $0.2 during the last trading session, hitting $6.54. About 472,203 shares traded hands. Sangamo Biosciences, Inc. (NASDAQ:SGMO) has risen ...
05/25/16 10:50 AMSangamo BioSciences, Inc. (NASDAQ:SGMO) Closes At $6.47 - Investor Newswire - Sangamo BioSciences, Inc. (NASDAQ:SGMO) Closes At $6.47Investor NewswireYesterday, the stock of Sangamo BioSciences, Inc. (NASDAQ:SGMO) closed at $6.47 after opening at $6.54 and registering high of $6.77 and low of $6.46. The last price is $-6.67 off 1-year high of $13.38 and $2.08 away from low of $4.63 during same ...Sangamo BioSciences, Inc. (NASDAQ:SGMO) Updated Price TargetsFTSE NewsEarnings Review and Stock Rundown for Sangamo BioSciences, Inc. (NASDAQ:SGMO)Wall Street Hints and NewsSangamo BioSciences, Inc. (NASDAQ:SGMO) Latest Broker ViewsRisers & FallersMarket Digestall 6 news articles »
05/23/16 01:01 PMStock Rating Review for Sangamo BioSciences, Inc. (NASDAQ:SGMO) - Wall Street Hints and News - Stock Rating Review for Sangamo BioSciences, Inc. (NASDAQ:SGMO)Wall Street Hints and NewsCovering equity analysts presently have a consensus stock rating of 1 on shares of Sangamo BioSciences, Inc. (NASDAQ:SGMO). Covering analysts will often provide Sell, Hold, or Buy recommendations based on their advanced research. This consensus ...and more »
05/23/16 07:36 AMSangamo BioSciences, Inc. breached its 50 day moving average in a Bullish Manner : SGMO-US : May 23, 2016 -
05/21/16 07:13 PMAlpha One Assigns Impact Score Of 0 To Sangamo BioSciences, Inc. (NASDAQ:SGMO) - Stocks Daily - Alpha One Assigns Impact Score Of 0 To Sangamo BioSciences, Inc. (NASDAQ:SGMO)Stocks DailyAlpha One analyzed the various web articles published on Sangamo BioSciences, Inc. (NASDAQ:SGMO), and thereafter it gave company a daily sentiment score of 0.046. The entity designs algorithm based assessment to known stock sentiment on stock after ...and more »
05/21/16 07:13 PMSangamo BioSciences, Inc. (NASDAQ:SGMO) Reports Basic Consolidated EPS At $-0.5835 - Stocks Daily - Sangamo BioSciences, Inc. (NASDAQ:SGMO) Reports Basic Consolidated EPS At $-0.5835Stocks DailyFor the year ended 2015-12-31 Sangamo BioSciences, Inc. (NASDAQ:SGMO) reported basic consolidated EPS of $-0.5835. The basic consolidated EPS stood at $-0.5835 for the quarter ended 2015-12-31. Per-share earnings form a part of the distributable ...Sangamo Biosciences Incorporated (NASDAQ:SGMO) Shorted Shares Increased By 3.2%The Postall 2 news articles »
05/18/16 11:36 AMSangamo BioSciences Inc. (SGMO) is Trading Lower on Unusual Volume for May 16 - Equities.com - Sangamo BioSciences Inc. (SGMO) is Trading Lower on Unusual Volume for May 16Equities.comSangamo BioSciences Inc. (SGMO) experienced unusually high volume on May. 16, as the stock lost 2.13% to a closing price of $5.97. The stock saw 1.55 million shares trade hands over the course of the day on 9,485 trades. Given that the stock's average ...What Analyst's have to say about Sangamo Biosciences, Inc. (NASDAQ:SGMO)CWRU ObserverSangamo Biosciences, Inc. (NASDAQ:SGMO) can increase its stock value upto $30.00News OracleInvestors Targeted Stocks: TherapeuticsMD, Inc. (NYSEMKT:TXMD) , Sangamo BioSciences, Inc. (NASDAQ:SGMO)Street UpdatesZergwatch -Franklin Independent -Trade Callsall 7 news articles »
05/16/16 01:20 PMAnalysis EPS Report: Sangamo Biosciences, Inc. (NASDAQ:SGMO) - News Oracle - News OracleAnalysis EPS Report: Sangamo Biosciences, Inc. (NASDAQ:SGMO)News OracleLast Trade: The Company rose 1.67% and finished at $6.10. The daily volume was measured at 1.04 million shares. The 52-week high of the share price is $13.38 and the 52-week low is $4.63. The company has a market cap of $437.17 million. Its latest ...and more »
05/14/16 04:19 AMWere Analysts Bearish Sangamo Biosciences, Inc. (NASDAQ:SGMO) This Week? - Wall Street Hints and News - Were Analysts Bearish Sangamo Biosciences, Inc. (NASDAQ:SGMO) This Week?Wall Street Hints and NewsOut of 5 analysts covering Sangamo Biosciences (NASDAQ:SGMO), 7 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. Sangamo Biosciences has been the topic of 8 analyst reports since August 8, 2015 according to StockzIntelligence ...Stock Earnings Overview: Sangamo Biosciences (NASDAQ:SGMO)News Oracleall 2 news articles »
05/14/16 04:19 AMSangamo BioSciences Inc. (SGMO) is Trading Lower on Unusual Volume for May 12 - Equities.com - Sangamo BioSciences Inc. (SGMO) is Trading Lower on Unusual Volume for May 12Equities.comSangamo BioSciences Inc. (SGMO) experienced unusually high volume on May. 12, as the stock lost 0.33% to a closing price of $6.00. The stock saw 1.58 million shares trade hands over the course of the day on 7,535 trades. Given that the stock's average ...
05/10/16 09:52 PMPerformance Recap and Target Perspective on Sangamo BioSciences, Inc. (NASDAQ:SGMO) - B.O.D.Y Confidential - Performance Recap and Target Perspective on Sangamo BioSciences, Inc. (NASDAQ:SGMO)B.O.D.Y ConfidentialIn the latest trading session, shares of Sangamo BioSciences, Inc. (NASDAQ:SGMO) moved +4.24%. In order to gain some further insight on stock performance, we can take a look at the stock price relative to some moving averages. After a recent check, ...and more »
05/10/16 03:18 PMSangamo BioSciences Announces Participation At Upcoming Investor Conferences - [at noodls] - RICHMOND, Calif., May 10, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today that Edward Lanphier, Sangamo's president and chief executive ...
05/09/16 06:16 AMSangamo BioSciences Presents Recent Developments From Research And ZFP Therapeutic® Programs In Multiple Presentations At Annual Meeting of the American Society of Gene and Cell Therapy - [at noodls] - RICHMOND, Calif., May 9, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, presented new preclinical data from the Company's proprietary In Vivo Protein ...
05/09/16 03:35 AMSangamo BioSciences, Inc. (NASDAQ:SGMO) Broker Price Targets For The Coming Week - Share Trading News - Sangamo BioSciences, Inc. (NASDAQ:SGMO) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of Sangamo BioSciences, Inc. (NASDAQ:SGMO). The latest reports which are currently in issue on Sunday 8th of May state 0 analysts have a rating of “strong buy”, 0 analysts ...Sangamo BioSciences, Inc. (NASDAQ:SGMO) Basic Consolidated EPS At $-0.5835Stocks DailySangamo Biosciences Incorporated (NASDAQ:SGMO) Shorts Decreased by 4.59% After Short CoveringThe Postall 3 news articles »
05/07/16 07:18 PMSangamo BioSciences, Inc. (NASDAQ:SGMO) Boasts An Average Rating Of 3 - Stocks Daily - Sangamo BioSciences, Inc. (NASDAQ:SGMO) Boasts An Average Rating Of 3Stocks DailyAlpha One applies algorithm-based analytics for assessing a stock sentiment as per the published released on web channels. In this evaluation process, the group accesses the most relevant news platforms on a daily basis. Sangamo BioSciences, Inc.and more »
05/07/16 07:18 PMSangamo BioSciences, Inc. (NASDAQ:SGMO) Basic Consolidated EPS At $-0.5835 - Stocks Daily - Sangamo BioSciences, Inc. (NASDAQ:SGMO) Basic Consolidated EPS At $-0.5835Stocks DailyThe basic EPS generating from continuing operations as announced by Sangamo BioSciences, Inc. (NASDAQ:SGMO) for the period ended 2015-12-31 was $-0.5835. For the quarter ended 2015-12-31, this number was $-0.5835. For any specified firm's ...
05/06/16 05:18 AMIntraday Active Biotech Stocks News: Synthetic Biologics Inc. (NYSEMKT:SYN), Sangamo Biosciences Inc. (NASDAQ ... - Street Register - Intraday Active Biotech Stocks News: Synthetic Biologics Inc. (NYSEMKT:SYN), Sangamo Biosciences Inc. (NASDAQ ...Street RegisterSangamo Biosciences Inc. (NASDAQ:SGMO) closed at $5.6, down -0.45 points or -7.44% from previous close. The latest insider trading filings show President & CEO LANPHIER EDWARD O II has disposed of 25,000 shares,reducing the stake to 235,000 ...and more »
05/05/16 04:54 PMETF’s with exposure to Sangamo BioSciences, Inc. : May 5, 2016 -
05/05/16 03:44 PMSANGAMO BIOSCIENCES INC Files SEC form 10-Q, Quarterly Report -
05/05/16 05:10 AMSangamo BioSciences Inc. (SGMO) Drops 6.64% on May 03 - Equities.com - Sangamo BioSciences Inc. (SGMO) Drops 6.64% on May 03Equities.comSangamo BioSciences Inc. (SGMO) was one of the Russell 2000's biggest losers for Tuesday May 03 as the stock slid 6.64% to $6.05, a loss of $-0.43 per share. Starting at an opening price of $6.64 a share, the stock traded between $6.04 and $6.81 over ...
05/04/16 12:49 PMSangamo BioSciences, Inc. :SGMO-US: Earnings Analysis: Q1, 2016 By the Numbers -
05/04/16 07:15 AMSangamo BioSciences, Inc. breached its 50 day moving average in a Bearish Manner : SGMO-US : May 4, 2016 -
05/03/16 02:22 AMSangamo BioSciences Inc.: Sangamo BioSciences Reports First Quarter 2016 Financial Results - RICHMOND, Calif., May 2, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, today reported its first quarter 2016 financial results and accomplishments. 'During the first quarter of 2016 we focused on ...
05/02/16 04:15 PMSangamo reports 1Q loss -
05/02/16 03:36 PMSANGAMO BIOSCIENCES INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and E -
05/02/16 03:20 PMSangamo BioSciences Reports First Quarter 2016 Financial Results - [at noodls] - RICHMOND, Calif., May 2, 2016 /PRNewswire/ -- Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, today reported its first quarter 2016 financial results and accomplishments. ...
About Sangamo Biosciences

Sangamo Biosciences logoSangamo Biosciences Inc. is a clinical-stage biopharmaceutical company. The Company is focused on research, development and commercialization of engineered deoxyribonucleic acid (DNA)-binding proteins for therapeutic genome editing and gene regulation. It is engaged in developing zinc finger DNA-binding proteins (ZFP) therapeutics. Its ZFP Therapeutic, SB-728, a ZFP nuclease (ZFN)-modified autologous cell product for the treatment of Human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS), is the therapeutic application of its ZFN genome editing technology and is evaluated in an ongoing Phase II study of ZFN-modified T-cells (SB-728-T-1101, Cohort 3) and a Phase I/II study of modified hematopoietic stem cells (SB-728mR-HSPC) in HIV-infected subjects. It has preclinical programs in hemophilia A and Lysergic acid diethylamide and research stage programs in monogenic diseases, including certain central nervous system disorders and cancer immunotherapy.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: SGMO
  • CUSIP: 80067710
Key Metrics:
  • Previous Close: $5.77
  • 50 Day Moving Average: $6.27
  • 200 Day Moving Average: $6.49
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $406.74M
  • Current Quarter EPS Consensus Estimate: $-0.98 EPS
Additional Links:
Sangamo Biosciences (NASDAQ:SGMO) Chart for Wednesday, June, 29, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha